+987.9%
MRNA vs DUOL
-38.2%
+1,026.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | DUOL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +26.0% | -12.9% | +4.2% |
| 7D | +20.6% | +19.3% | +1.4% | +13.0% |
| 30D | +27.1% | +9.6% | +17.5% | +22.1% |
| 3M | +353.4% | +17.1% | +336.3% | +329.8% |
| 6M | +446.3% | +46.3% | +400.0% | +412.1% |
| YTD | +776.2% | -8.1% | +784.3% | +788.9% |
| 1Y | +987.9% | -38.5% | +1,026.4% | +1,021.3% |
| All | +987.9% | -38.2% | +1,026.1% | +1,021.3% |
Cumulative growth
Daily Returns
Daily percentage return beside DUOL.
Daily Out/Under-Performance
Portfolio return minus DUOL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DUOL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded DUOL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling